Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corgenix to Host Conference Call to Discuss Fiscal Third Quarter 2007 Financial Results.


DENVER -- Corgenix Medical Corporation (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Tuesday, May 15, 2007 at 3:00 PM EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
 to discuss the Company's financial and operating performance for its third quarter, as well as the status of the Company's product development and marketing activities.

Corgenix invites all those interested in hearing management's discussion of third quarter results to join the call by dialing 866-585-6398. International participants may access the call by dialing 416-849-9626. A replay will be available for one week following the call by dialing 866-245-6755 for domestic participants and 416-915-1035 for international participants and entering passcode 609559 when prompted.

About Corgenix Medical Corporation

Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology immunology, branch of medicine that studies the response of organisms to foreign substances, e.g., viruses, bacteria, and bacterial toxins (see immunity). Immunologists study the tissues and organs of the immune system (bone marrow, spleen, tonsils, thymus, lymphatic  disorders, vascular diseases vascular diseases,
n.pl diseases of the peripheral circulatory system.
 and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 process. More information is available at www.corgenix.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 7, 2007
Words:184
Previous Article:Med Gen Announces Current Financial Information.
Next Article:Avago Technologies Announces Industry's Thinnest Leadframe ChipLEDs for Automotive, Electronic Sign and Industrial Applications.
Topics:



Related Articles
Corgenix Executes Private Placement Agreements Representing Initial Gross Proceeds of $3.36 Million.
Corgenix to Host Conference Call to Discuss Second Quarter Fiscal 2006 Results.
Corgenix Reports Third Quarter Fiscal 2006 Results.
Corgenix to Host Conference Call to Discuss Fiscal Fourth Quarter and 2006 Year-End Results.
Corgenix to Present at Rodman & Renshaw Techvest 8th Annual Healthcare Conference on November 8, 2006.
Corgenix to Release Fiscal 2007 First Quarter Results and Host Conference Call on November 14, 2006.
Corgenix Reports Record Revenue for First Quarter of Fiscal 2007.
Corgenix to Release Fiscal 2007 Second Quarter Results and Host Conference Call on February 14, 2007.
Corgenix Reports Second Quarter Fiscal 2007 Financial Results.
Corgenix Reports 23% Increase in Revenue for Third Quarter Fiscal 2007.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles